If you weren’t able to attend the 2023 Fall Clinical Dermatology Conference or want to review our latest coverage and interviews, our full recap has you covered.
Among the many sessions to be held at the 2023 Fall Clinical Dermatology Conference in Las Vegas, Nevada, several Dermatology Times® Editorial Advisory Board members are preparing to share their knowledge and insights.
Click here to answer if you're attending Fall Clinical.
One of the many minds behind innovative Fall Clinical Dermatology sessions gives a sneak peek of the top 5 things to look forward to during this year's meeting.
One of the largest dermatology meetings of the year kicks off today with an exciting line up of expert perspectives and clinical pearls. Here's what you can expect.
Looking to explore the city between Fall Clinical sessions or to extend your stay? Check out this top 10 list of the best Las Vegas has to offer in October.
Cheryl Burgess, MD, will share pearls on counseling patients on appropriate cosmetic procedures for their skin type, safety measures, and strategies to achieve desired outcomes.
Farberg is looking forward to another year of top-notch presentations at Fall Clinical 2023.
Test your knowledge on the foundation leading to the development of biologics to treat atopic dermatitis.
Bhatia also shared insights into ritlecitinib for alopecia areata at Fall Clinical 2023.
Catch up on coverage from the first day of the 2023 Fall Clinical Dermatology Conference and the Inflammatory Disease Summit.
Kwatra reviewed skin lesions in PN and important treatment considerations for patients at Fall Clinical.
April Armstrong, MD, MPH, and Peter Lio, MD, explained the science behind how AD impacts quality of life and biologics on the market to enhance treatment plans.
Francesca Tenconi, president and CEO of Children’s Skin Disease Foundation and Camp Wonder, presented at Fall Clinical 2023 about the challenges of chronic skin conditions in children.
Catch up on coverage from the second day of the 2023 Fall Clinical Dermatology Conference.
Dawn Merritt, DO, and Mark Lebwohl, MD, took the stage to explain the history of CSU, the prevalence of testing and food avoidance, approved treatments, and monitoring treatment improvement for the condition.
Shah is presenting alongside a panel of leading experts at Fall Clinical 2023.
The positive outcomes observed in these cases underscore the potential for these products to revolutionize the way dermatology clinicians address visible signs of facial aging.
The goal of Arron et al’s study was to determine if the 40-GEP test could identify high-risk cSCC patients who would benefit from ART in controlling metastatic disease progression.
The pharmacokinetic profile of APG777, characterized by an extended half-life, increased exposure, and reduced clearance compared to lebrikizumab, is promising for patients with IL-13-driven diseases.
Christopher Bunick, MD, PhD, reviews Cabtreo’s recent FDA approval and what the new triple-combination gel means for acne patients.
Although still in its early stages, the program showcases the potential value of tangible interactions between dedicated navigators and patients in enhancing support and continuity of care.
Catch up on coverage from the third day of the 2023 Fall Clinical Dermatology Conference.
The latest CDC data shows an uptick in syphilis, which can lead to a rare form of alopecia or a presentation of psoriasis.
Primary and secondary melanoma prevention factors are necessary to reduce patients’ melanoma risk.
Sandra Lee, MD, and other top acne experts took the stage to debate cases and treatments.
Kirby presented at both Fall Clinical and the Inflammatory Disease Summit in Las Vegas.
Susan Taylor, MD, walked Fall Clinical attendees through an in-depth hyperpigmentation session that included melasma and its mimickers.
There is a lot of conversation drumming around the boxed warnings for newer JAK inhibitors, and fact versus fiction was discussed at Fall Clinical.
This study aimed to evaluate the association between the disease burden of psoriasis and the switching of systemic biologic therapies in patients with both psoriasis and psoriatic arthritis.
Catch up on coverage from the final day of the 2023 Fall Clinical Dermatology Conference.